| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |